Skip to content

Emanuele Mazzola

3 papers in the library · 1 citation · publishing 2023-2026

Papers

Sort Most recent Most cited

Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.

Journal of Pain and Symptom Management August 1, 2026 Daniel A. Schaefer, Manish Agrawal, Emanuele Mazzola et al.

CONTEXT Psilocybin-assisted therapy has demonstrated rapid antidepressant effects in patients with cancer, but most trials have excluded individuals receiving active systemic anticancer treatment, limiting safety data in this population. OBJECTIVES To compare the efficacy and safety of psilocybin-assisted therapy in patients receiving versus not receiving concurrent systemic anticancer...

Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy

BMJ Supportive & Palliative Care November 3, 2025 Yvan Beaussant, Zachary Sager, Caitlin W. Brennan et al. 1 citation

Objectives To assess the feasibility, safety and preliminary efficacy of psilocybin-assisted therapy (PAT) for demoralisation in terminally ill patients receiving home hospice care. Methods In this open-label pilot trial, 4607 home hospice patients at a large community hospice were screened over 22 months; 66 were approached, 15 enrolled and 10 received psilocybin. Participants completed two...

DOI: 10.1136/spcare-2025-005773 (opens in new tab) Terminally ill Medline Hospice care Patient safety +3

Exploring Influencing Factors of Anxiety Improvement Following Mindfulness-Based Music Therapy in Young Adults with Cancer.

Journal of Music Therapy June 1, 2023 Robert Knoerl, Emanuele Mazzola, Heather Woods et al.

The purpose of this secondary analysis was to explore physiological, psychological, and situational influencing factors that may affect the impact of a mindfulness-music therapy intervention on anxiety severity in young adults receiving cancer treatment. Young adults receiving cancer treatment for ≥ eight weeks were recruited from adult and pediatric oncology outpatient centers at Dana-Farber...